Former WWE and UFC Heavyweight Champion Brock Lesnar has been flagged by the U.S. Anti-Doping Agency for a potential anti-doping violation that stems from an failure of an out-of-competition drug test that took place on June 28th.
The Ultimate Fighting Championship announced that USADA received the results on July 14th, five days after Lesnar’s UFC 200 fight against Mark Hunt. Per their policy, USADA has not disclosed the substance that Lesnar tested positive for.
Below is the UFC’s official statement regarding the matter:
“The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Brock Lesnar of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collection on June 28, 2016. USADA received the testing results from the June 28, 2016 sample collection from the WADA-accredited UCLA Olympic Analytical Laboratory on the evening of July 14, 2016.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed. The Nevada State Athletic Commission also retains jurisdiction over this matter as the sample collection was performed in close proximity to Lesnar’s bout at UFC 200 in Las Vegas.
Consistent with all previous potential anti-doping violations, additional information will be provided at the appropriate time as the process moves forward.”